Morningstar: Johnson & Johnson fair value estimate should remain unchanged following opiod ruling
Update: 2025-09-23
Description
Morningstar: Johnson & Johnson fair value estimate should remain unchanged following opiod ruling. In one of the first state opiod cases, an Oklahoma judge has ruled against Johnson & Johnson. But overall, Morningstar doesn't expect any change to our fair value estimate or moat rating and we continu....
This item belongs to: audio/rivet360-audio-collection.
This item has files of the following types: Archive BitTorrent, Columbia Peaks, Item Tile, Metadata, PNG, Spectrogram, VBR MP3
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
x
